Conrad Wai is CEO at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). They have made 1 open-market trade across 1 company since 2025, most recently 2026-09-15.
CIK 0001971702
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLOV | 1,170,056 | $5.2M |
Shares reported on the most recent Form 4, priced at the 2026-09-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLOV | SELL · 10b5-1 | 2026-09-15 | 2026-09-16 | $4.72 | $1.4M | -5.2% | -2.1% | — |
| CLOV | SELL | 2026-07-15 | 2026-07-16 | $4.67 | $113K | -0.2% | -1.4% | +10.1% |
| CLOV | SELL · 10b5-1 | 2026-05-28 | 2026-05-28 | $3.99 | $879K | +4.5% | +30.1% | +3.9% |
| CLOV | SELL · 10b5-1 | 2025-07-22 | 2025-07-24 | $3.31 | $996K | -7.5% | -14.1% | +0.0% |
| CLOV | SELL · 10b5-1 | 2025-07-08 | 2025-07-10 | $3.26 | $50K | +7.0% | -17.9% | -7.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.